Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AZN compared with EQT: revenue, margins and what each company keeps, and the suppliers and customers both name
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
EQT
EQT Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
AZN
Astrazeneca PLC
vs
EQT
EQT Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AZN: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AZN
20
ARQT
Arcutis Biotherapeutics
customer
GRAL
Grail
supplier
RCUS
Arcus Biosciences
customer
NKTR
Nektar Therapeutics
supplier
16 more · AZN chain
›
Shared
0
No shared counterparties.
Only EQT
2
NEXT
NextDecade
supplier
WHK
WhiteHawk Minerals
supplier
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AZN, solid
EQT, dashed
AZN
Astrazeneca PLC
Change
183.83
▼
−1.47%
Mkt cap
$289.4B
Revenue
—
Revenue
—
EQT
EQT Corp
Change
54.81
▼
−0.06%
Regular session
Nov 3 '26
Mkt cap
$34.3B
Revenue
$1.8B
Q3 FY26
Revenue
$8.6B
FY25
vs
Compare
Regular session
Nov 3 '26
AZN
Astrazeneca PLC
vs
EQT
EQT Corp
183.83
▼
−1.47%
Price
54.81
▼
−0.06%
$289.4B
Mkt cap
$34.3B
—
Revenue
$1.8B
Q3 FY26
—
Revenue
$8.6B
FY25
Change
Change
AZN
183.83
▼
−1.47%
vs
EQT
54.81
▼
−0.06%
Regular session
Nov 3 '26